Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve the Standalone & Consolidated ....
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has informed BSE that its Board of Directors will meet on Monday, 19th May 2025 at 2:00 PM at its registered office in Amritsar. The main agenda is to consider and approve the Standalone and Consolidated audited financial results for the fourth quarter and the full financial year ended 31st March 2025. The trading window for insiders, designated persons, and their immediate relatives remains closed until 48 hours after the results are made public. The filing is a standard regulatory intimation under SEBI LODR Regulations and does not contain any actual financial numbers yet.
This is a routine pre-results announcement, so there is no direct impact on the stock price from this filing itself. Investors should watch for the actual audited numbers on or after 19th May 2025, which will be the first real catalyst for the stock.